Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Crit Rev Toxicol ; 41(6): 507-44, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21591905

RESUMEN

Quantitative methods for estimation of cancer risk have been developed for daily, lifetime human exposures. There are a variety of studies or methodologies available to address less-than-lifetime exposures. However, a common framework for evaluating risk from less-than-lifetime exposures (including short-term and/or intermittent exposures) does not exist, which could result in inconsistencies in risk assessment practice. To address this risk assessment need, a committee of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute conducted a multisector workshop in late 2009 to discuss available literature, different methodologies, and a proposed framework. The proposed framework provides a decision tree and guidance for cancer risk assessments for less-than-lifetime exposures based on current knowledge of mode of action and dose-response. Available data from rodent studies and epidemiological studies involving less-than-lifetime exposures are considered, in addition to statistical approaches described in the literature for evaluating the impact of changing the dose rate and exposure duration for exposure to carcinogens. The decision tree also provides for scenarios in which an assumption of potential carcinogenicity is appropriate (e.g., based on structural alerts or genotoxicity data), but bioassay or other data are lacking from which a chemical-specific cancer potency can be determined. This paper presents an overview of the rationale for the workshop, reviews historical background, describes the proposed framework for assessing less-than-lifetime exposures to potential human carcinogens, and suggests next steps.


Asunto(s)
Carcinógenos/toxicidad , Exposición a Riesgos Ambientales/normas , Mutágenos/toxicidad , Bioensayo/métodos , Carcinógenos/administración & dosificación , Bases de Datos Factuales , Árboles de Decisión , Relación Dosis-Respuesta a Droga , Determinación de Punto Final , Contaminación de Alimentos/análisis , Guías como Asunto , Productos Domésticos/efectos adversos , Humanos , Mutágenos/administración & dosificación , National Institute of Environmental Health Sciences (U.S.) , Neoplasias/inducido químicamente , Plaguicidas/efectos adversos , Medición de Riesgo , Factores de Tiempo , Estados Unidos , United States Environmental Protection Agency , United States Food and Drug Administration
2.
Birth Defects Res B Dev Reprod Toxicol ; 74(3): 268-76, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15954087

RESUMEN

BACKGROUND: The individual effects of boric acid (BA) and hyperthermia on the development of the axial skeleton have been reported previously. Both cause an increased incidence of axial skeletal defects including a decrease in the total number of ribs and vertebrae. Because of the similarity in the effects of the two agents, we examined their interaction when given in combination to pregnant rats on gestational day (GD) 10. METHODS: Dams were treated on GD 10 with BA (0, 250, or 500 mg/kg) and hyperthermia (37, 41, or 42 degrees C) and allowed to deliver their pups. Doses of BA were based on results from a dose-finding study. Litters were evaluated on postnatal days (PND) 1 and 3 for number, gender, and weight of pups. On PND3, pups were examined externally and viscerally, and double-stained for skeletal evaluation. RESULTS: A dose-dependent, statistically significant increase in fetal skeletal defects was seen on PND 3 with BA or hyperthermia alone with even greater effects when given in combination. Defects included rib and vertebral fusions, split vertebral centra in the thoracic and lumbar areas, and a decrease in the total number of ribs and vertebrae. CONCLUSIONS: The increased incidence of skeletal defects resulting from combined exposure to hyperthermia and BA was additive for segmentation defects and synergistic for the reduction in numbers of vertebrae.


Asunto(s)
Anomalías Inducidas por Medicamentos , Ácidos Bóricos/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Calor , Insecticidas/toxicidad , Columna Vertebral/anomalías , Animales , Huesos/anomalías , Huesos/embriología , Femenino , Feto/anomalías , Masculino , Ratas , Ratas Sprague-Dawley , Columna Vertebral/embriología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...